— Know what they know.
Not Investment Advice
Also trades as: APLM (NASDAQ) · $vol 0M

APLMW NASDAQ

Apollomics, Inc.
1W: -10.3% 1M: -26.6% 3M: +26.5% YTD: -20.4% 1Y: -59.6% 3Y: -80.6%
$0.01
-0.00 (-21.64%)
 
Weekly Expected Move ±17.0%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 39 · $155.2M mcap · 223M float · 0.035% daily turnover · Short 17% of daily vol

Cash Flow Trends

Operating Cash Flow
-$29M +33.5% ▲
Capital Expenditures
$24K -300.0% ▼
5Y CAGR: -51.1%
Free Cash Flow
-$29M +33.4% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$22M -3501.0% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$75M-$95M-$241M-$173M-$54M
Depreciation & Amort.$4M$681K$775K$669K$361K
Stock-Based Comp.$5M$8M$4M$13M$11M
Change in Working Capital-$940K-$453K$4M-$932K$2M
Other Non-Cash Items$31M$43M$190M$117M$12M
Operating Cash Flow-$36M-$43M-$43M-$43M-$29M
— Investing Activities —
Capital Expenditures-$144K-$50K-$367K-$6K-$24K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$2M-$39M$29M$21M$6M
Investing Cash Flow$2M-$39M$29M$21M$6M
— Financing Activities —
Net Debt Issuance-$472K-$528K-$593K-$444K-$170K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$72K-$83K-$93K$4M-$4M
Financing Cash Flow$126M-$2M-$294K$21M$468K
Net Change in Cash$92M-$84M-$14M-$619K-$22M
Cash End of Period$131M$47M$33M$32M$10M
Free Cash Flow-$36M-$43M-$43M-$43M-$29M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms